What is the recommended treatment for a patient with an Enterococcus faecalis urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Enterococcus faecalis UTI

For uncomplicated E. faecalis UTI, treat with amoxicillin 500 mg orally every 8 hours for 7 days as first-line therapy, achieving 88.1% clinical cure and 86% microbiological eradication rates. 1, 2

Treatment Algorithm by Clinical Scenario

Uncomplicated UTI (Outpatient, Lower Tract)

First-line options:

  • Amoxicillin 500 mg orally every 8 hours for 7 days - preferred agent per American College of Physicians 1, 2
  • Ampicillin 500 mg orally every 8 hours for 7 days - equivalent alternative 1, 2
  • Fosfomycin 3 g orally as single dose - FDA-approved specifically for E. faecalis UTI, convenient for uncomplicated infections 1, 2

Alternative for penicillin allergy:

  • Nitrofurantoin 100 mg orally every 6 hours for 7 days - resistance rates below 6%, good in vitro activity 1, 2

Complicated UTI or Pyelonephritis (Hospitalized, IV Therapy Required)

First-line IV therapy:

  • High-dose ampicillin 18-30 g IV daily in divided doses (or amoxicillin 500 mg IV every 8 hours) - achieves sufficient urinary concentrations to overcome even high MICs 1, 2

Alternative IV agents for complicated UTI:

  • Linezolid 600 mg IV every 12 hours for 5-7 days - strongly recommended 2
  • Daptomycin 6-12 mg/kg IV daily for 5-7 days 2

Vancomycin-Resistant E. faecalis (VRE)

For uncomplicated VRE UTI:

  • Fosfomycin 3 g orally single dose or every other day 2
  • Nitrofurantoin 100 mg orally four times daily for 3-7 days 2
  • High-dose ampicillin 18-30 g/day IV in divided doses - recommended despite in vitro resistance because urinary concentrations overcome elevated MICs 1, 2

For complicated VRE UTI with bacteremia:

  • Daptomycin 8-12 mg/kg/day IV 1
  • Linezolid - reserved for confirmed or suspected upper tract/bacteremic VRE among ampicillin-resistant strains per Infectious Diseases Society of America 1

Critical Clinical Considerations

Always obtain susceptibility testing before initiating therapy, even for strains described as "pansensitive," as resistance patterns vary significantly by institution 1, 2

Differentiate colonization from true infection - asymptomatic bacteriuria with E. faecalis does not routinely require treatment 1

Avoid fluoroquinolones - ciprofloxacin/levofloxacin resistance rates are 46-47%, making them inappropriate choices 1, 3

For beta-lactamase producing strains, replace amoxicillin with amoxicillin-clavulanate for 7 days 1

Important Contraindications and Limitations

Nitrofurantoin restrictions:

  • Do NOT use for complicated UTI or pyelonephritis - achieves poor tissue and serum concentrations 1
  • Do NOT use for systemic enterococcal infections (bacteremia, endocarditis, intra-abdominal infections) 1
  • Contraindicated if creatinine clearance <60 mL/min - urinary concentrations become inadequate 1

Cephalosporins should be avoided - E. faecalis has natural resistance to all cephalosporins per European Society of Cardiology 1

Treatment Duration

  • Uncomplicated lower UTI: 7 days 1, 2
  • Complicated UTI: 5-7 days 2
  • Pyelonephritis: 7-14 days 2
  • Duration should be based on clinical response, site of infection, and underlying comorbidities 1, 2

References

Guideline

Treatment for Enterococcus faecalis in Urine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Antibiotic Treatment for Enterococcus UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.